Patent · US Active

Transferrin receptor antibodies

US8187594B2 · kind B2 · utility

19Cited by
4References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2009
Grant dateMay 29, 2012
Priority date
Expiry dateMar 19, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/809
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.